PDLI earnings call for the period ending March 31, 2019.
News & Analysis: PDL BioPharma
PDLI earnings call for the period ending December 31, 2018.
These low-priced stocks could generate high returns.
These low-priced stocks could generate huge returns. But there are huge risks, too.
This former dividend star now has a cash stockpile greater than its market cap.
But are they bargains or busts?
You'll probably be surprised by some of the stock picks from a leading artificial-intelligence system.
High-yielding pharma and biotech stocks should probably come with a warning label.
Despite a down market, these stocks gained ground. Find out why.
Investors are cheering an incredible profit improvement announced Thursday afternoon. But there's a good reason they aren't cheering more loudly.